The stock's fall snapped a three-day winning streak.

Appointment adds business, market and partner development expertise to FYR board Addition highlights FYR’s evolution into ...

Shares of Labcorp Holdings Inc. LH inched 0.34% higher to $229.92 Monday, on what proved to be an all-around mixed trading ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

LabCorp and University Health System settle on $388,667 for alleged False Claims Act violations related to Medicare billing.

The Federal Circuit rejected Laboratory Corporation of America Holdings’ challenge of a competitor’s fetal DNA test patent ...

The U.S. Attorney's Office said the two corporations delayed certain laboratory tests by Caris Life Sciences between March ...

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Labcorp Holdings (NYSE:LH) from In-Line ...

In the preceding three months, 8 analysts have released ratings for Labcorp Holdings LH +2.25% Get Free Report , presenting a wide array of perspectives from bullish to bearish. The following table ...

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests Bio-Rad leads ...

The Federal Circuit on Monday, January 6, rejected Labcorp's argument that the Patent Trial and Appeal Board erred in its ...

Labcorp Holdings Inc. LH, or Labcorp, is targeting high-growth areas as part of its expansion. By partnering with health systems and regional local laboratories, the company is leveraging science and ...